2026 Q3 Portfolio Activity
In 2026 Q3, Jones Hill Capital LP maintained a portfolio of 48 distinct positions. The most significant new addition was BIOCRYST PHARMACEUTICALS INC, now representing 10.01% of the total fund value. They heavily accumulated shares in PHARVARIS N V, increasing the position by 45.7%. Conversely, Jones Hill Capital LP completely exited their position in GILEAD SCIENCES INC.
Position History
hover any row below to update
Loading…
Jones Hill Capital LP
AUM $589M
Total Positions
48
Quarter
2026 Q3
Top Holding
BMRN (11.9%)
Top 10 Concentration
68.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-48 of 48
Jones Hill Capital LP Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 11.93% | 17.42% |
#1
Prev: #1
|
6.5 |
—
|
-259,731 | -18.1% |
P
S
|
1,171,859 | $70,311,540 |
$56.57
+3.4%
|
2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 10.01% | — |
#2
Prev: #—
|
9.0 |
—
|
7,083,300 | — |
NEW
|
7,083,300 | $59,003,889 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 9.59% | — |
#3
Prev: #—
|
8.3 |
—
|
959,634 | — |
NEW
|
959,634 | $56,503,250 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
INDV
INDIVIOR PHARMA...
|
Healthcare | 9.29% | — |
#4
Prev: #—
|
7.7 |
—
|
1,526,685 | — |
NEW
|
1,526,685 | $54,731,657 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 5.32% | 4.98% |
#5
3
Prev: #8
|
5.1 |
—
|
309,758 | 45.7% |
P
S
|
987,637 | $31,327,846 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CELC
CELCUITY INC
|
Healthcare | 5.17% | — |
#6
Prev: #—
|
5.6 |
—
|
382,901 | — |
NEW
|
382,901 | $30,448,288 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 4.55% | — |
#7
Prev: #—
|
5.3 |
—
|
599,826 | — |
NEW
|
599,826 | $26,782,231 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SUPN
SUPERNUS PHARMA...
|
Healthcare | 4.40% | — |
#8
Prev: #—
|
5.3 |
—
|
601,685 | — |
NEW
|
601,685 | $25,896,522 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 4.26% | — |
#9
Prev: #—
|
5.2 |
—
|
4,486,986 | — |
NEW
|
4,486,986 | $25,127,122 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 3.57% | — |
#10
Prev: #—
|
4.9 |
—
|
652,218 | — |
NEW
|
652,218 | $21,060,119 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 3.52% | 5.31% |
#11
4
Prev: #7
|
3.4 |
—
|
107,944 | 8.1% |
P
S
|
1,447,156 | $20,723,274 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
BCAX
BICARA THERAPEU...
|
Healthcare | 3.36% | 5.63% |
#12
7
Prev: #5
|
3.3 |
—
|
171,612 | 19.2% |
P
S
|
1,064,233 | $19,805,376 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RLMD
RELMADA THERAPE...
|
Healthcare | 3.35% | 5.38% |
#13
7
Prev: #6
|
3.8 |
—
|
1,582,553 | 43.3% |
P
S
|
5,237,628 | $19,745,858 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 2.40% | — |
#14
Prev: #—
|
4.5 |
—
|
142,558 | — |
NEW
|
142,558 | $14,116,093 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ACRS
ACLARIS THERAPE...
|
Healthcare | 2.24% | 1.98% |
#15
1
Prev: #16
|
3.4 |
—
|
745,159 | 42.4% |
P
S
|
2,504,651 | $13,174,464 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
INSM
INSMED INC
|
Healthcare | 2.06% | 2.77% |
#16
3
Prev: #13
|
1.3 |
—
|
-15,847 | -12.9% |
P
S
|
106,528 | $12,159,106 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 2.01% | — |
#17
Prev: #—
|
4.3 |
—
|
83,426 | — |
NEW
|
83,426 | $11,833,144 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.98% | 3.46% |
#18
7
Prev: #11
|
0.8 |
—
|
-128,578 | -25.1% |
P
S
|
384,278 | $11,639,781 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ERAS
ERASCA INC
|
Healthcare | 1.52% | — |
#19
Prev: #—
|
4.1 |
—
|
610,118 | — |
NEW
|
610,118 | $8,944,330 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CAPR
CAPRICOR THERAP...
|
Healthcare | 1.43% | 2.15% |
#20
5
Prev: #15
|
3.6 |
—
|
471,781 | 112.1% |
P
S
|
892,532 | $8,452,278 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.20% | 1.18% |
#21
3
Prev: #24
|
3.0 |
—
|
22,917 | 40.1% |
P
S
|
80,017 | $7,045,497 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NGNE
NEUROGENE INC
|
Healthcare | 1.03% | — |
#22
Prev: #—
|
3.9 |
—
|
217,700 | — |
NEW
|
217,700 | $6,056,414 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 1.03% | 1.30% |
#23
Prev: #23
|
2.9 |
—
|
232,856 | 35.6% |
P
S
|
886,428 | $6,045,439 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TNXP
TONIX PHARMACEU...
|
Healthcare | 0.93% | 1.70% |
#24
5
Prev: #19
|
0.9 |
—
|
-61,689 | -9.9% |
P
S
|
563,739 | $5,490,818 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SGMT
SAGIMET BIOSCIE...
|
Healthcare | 0.84% | — |
#25
Prev: #—
|
3.8 |
—
|
502,587 | — |
NEW
|
502,587 | $4,965,560 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 0.82% | — |
#26
Prev: #—
|
3.8 |
—
|
300,900 | — |
NEW
|
300,900 | $4,847,499 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
AVLN
AVALYN PHARMACE...
|
Healthcare | 0.61% | — |
#27
Prev: #—
|
3.7 |
—
|
126,744 | — |
NEW
|
126,744 | $3,610,937 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
N/A
ATTOVIA THERAPE...
|
|
Unknown | 0.53% | — |
#28
Prev: #—
|
3.7 |
—
|
182,295 | — |
NEW
|
182,295 | $3,124,536 | — | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
PHAT
PHATHOM PHARMAC...
|
Healthcare | 0.34% | 0.37% |
#29
1
Prev: #28
|
3.1 |
—
|
115,344 | 71.4% |
P
S
|
276,830 | $2,020,859 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
LXEO
LEXEO THERAPEUT...
|
Healthcare | 0.34% | — |
#30
Prev: #—
|
3.6 |
—
|
593,737 | — |
NEW
|
593,737 | $2,006,831 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
OLMA
OLEMA PHARMACEU...
|
Healthcare | 0.30% | 1.53% |
#31
10
Prev: #21
|
0.1 |
—
|
-367,769 | -64.1% |
P
S
|
206,397 | $1,783,270 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TENX
TENAX THERAPEUT...
|
Healthcare | 0.04% | — |
#32
Prev: #—
|
3.5 |
—
|
122,169 | — |
NEW
|
122,169 | $230,899 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ALVO
ALVOTECH
|
Healthcare | 0.03% | — |
#33
Prev: #—
|
3.5 |
—
|
26,700 | — |
NEW
|
26,700 | $154,860 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ACHV
ACHIEVE LIFE SC...
|
Healthcare | 0.00% | 0.04% |
Sold All 😨
(Was: #29) |
0.0 |
—
|
-26,760 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.00% | 0.46% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-40,567 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.00% | 0.54% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-49,850 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 0.00% | 1.17% |
Sold All 😨
(Was: #25) |
0.0 |
—
|
-11,123 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 0.00% | 1.43% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-659,213 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.00% | 1.58% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-340,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.00% | 1.72% |
Sold All 😨
(Was: #18) |
0.0 |
—
|
-747,313 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IMUX
IMMUNIC INC
|
Healthcare | 0.00% | 1.76% |
Sold All 😨
(Was: #17) |
0.0 |
—
|
-539,814 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NUVL
NUVALENT INC
|
Healthcare | 0.00% | 2.58% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-98,442 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 0.00% | 3.41% |
Sold All 😨
(Was: #12) |
0.0 |
—
|
-894,058 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ANIP
ANI PHARMACEUTI...
|
Healthcare | 0.00% | 4.11% |
Sold All 😨
(Was: #10) |
0.0 |
—
|
-233,808 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 0.00% | 4.72% |
Sold All 😨
(Was: #9) |
0.0 |
—
|
-367,900 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 0.00% | 6.00% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-52,545 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 0.00% | 6.07% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-1,089,701 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
GILD
GILEAD SCIENCES...
|
Healthcare | 0.00% | 9.21% |
Sold All 😨
(Was: #2) |
0.0 |
—
|
-343,043 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 |
Showing 1-48 of 48 holdings